Scarica l'app Stockscreener
1.54
1.99%
0.03
Dopo l'orario di chiusura:
1.54
Panoramica
Notizia
Cronologia dei prezzi
Catena di opzioni
Financials
Perché MXCT Giù?
Forum
Previsione
Precedente Chiudi:
$1.51
Aprire:
$1.49
Volume 24 ore:
757.03K
Relative Volume:
0.91
Capitalizzazione di mercato:
$164.17M
Reddito:
$45.44M
Utile/perdita netta:
$-35.43M
Rapporto P/E:
-4.5294
EPS:
-0.34
Flusso di cassa netto:
$-25.39M
1 W Prestazione:
-5.52%
1M Prestazione:
-2.53%
6M Prestazione:
-45.77%
1 anno Prestazione:
-56.98%
Intervallo 1D:
$1.49
$1.58
Intervallo di 1 settimana:
$1.49
$1.67
Portata 52W:
$1.26
$5.20
Maxcyte Inc Stock (MXCT) Company Profile
Nome
Maxcyte Inc
Settore
Industria
Telefono
301-517-5556
Indirizzo
9713 KEY WEST AVENUE,, ROCKVILLE
Confronta MXCT con altri titoli
| Azioni | Prezzo | Cap. di mercato | Reddito | Reddito netto | Flusso di cassa | EPS |
|---|---|---|---|---|---|---|
MXCT
Maxcyte Inc
|
1.54 | 160.98M | 45.44M | -35.43M | -25.39M | -0.34 |
|
ABT
Abbott Laboratories
|
123.62 | 216.79B | 43.84B | 13.90B | 6.92B | 7.9725 |
|
BSX
Boston Scientific Corp
|
100.72 | 149.02B | 19.35B | 2.78B | 3.49B | 1.8696 |
|
SYK
Stryker Corp
|
356.24 | 141.06B | 24.38B | 2.94B | 4.02B | 7.6145 |
|
MDT
Medtronic Plc
|
90.70 | 116.68B | 34.20B | 4.69B | 5.30B | 3.6218 |
|
EW
Edwards Lifesciences Corp
|
82.45 | 49.01B | 5.88B | 1.34B | 577.90M | 2.3455 |
Maxcyte Inc Stock (MXCT) Upgrades & Downgrades
| Data | Azione | Analista | Modifica della valutazione |
|---|---|---|---|
| 2025-08-11 | Downgrade | BTIG Research | Buy → Neutral |
| 2025-08-07 | Downgrade | William Blair | Outperform → Mkt Perform |
| 2025-07-22 | Iniziato | Stephens | Overweight |
| 2023-11-29 | Iniziato | Craig Hallum | Buy |
| 2021-10-15 | Ripresa | Cowen | Outperform |
| 2021-08-24 | Iniziato | BTIG Research | Buy |
| 2021-08-24 | Iniziato | Cowen | Outperform |
| 2021-08-24 | Iniziato | Stephens | Overweight |
| 2021-08-24 | Iniziato | Stifel | Buy |
| 2021-08-24 | Iniziato | Wedbush | Outperform |
| 2021-08-24 | Iniziato | William Blair | Outperform |
Mostra tutto
Maxcyte Inc Borsa (MXCT) Ultime notizie
Reversal indicators forming on MaxCyte Inc. stockMarket Volume Summary & Fast Exit/Entry Strategy Plans - newser.com
Is MaxCyte Inc. stock a buy in volatile marketsSwing Trade & Real-Time Market Sentiment Reports - newser.com
Will breakout in MaxCyte Inc. lead to full recovery2025 Support & Resistance & Daily Oversold Bounce Ideas - newser.com
Why MaxCyte Inc. stock remains a top recommendation2025 Support & Resistance & Fast Entry Momentum Trade Alerts - newser.com
Will MaxCyte Inc. (MYE0) stock outperform benchmarksAnalyst Downgrade & High Conviction Trade Alerts - newser.com
Statistical indicators supporting MaxCyte Inc.’s strength2025 Pullback Review & High Accuracy Trade Signal Alerts - newser.com
Why MaxCyte Inc. stock could outperform in 2025July 2025 Sector Moves & Free Safe Capital Growth Stock Tips - newser.com
Can MaxCyte Inc. stock deliver strong Q4 earningsCEO Change & Free Community Consensus Stock Picks - newser.com
Backtesting results for MaxCyte Inc. trading strategiesJuly 2025 Selloffs & Fast Entry and Exit Trade Plans - newser.com
How to interpret RSI for MaxCyte Inc. stock2025 Big Picture & Growth Oriented Trade Recommendations - newser.com
Will MaxCyte Inc. (MYE0) stock see valuation expansion2025 Key Highlights & Smart Money Movement Alerts - newser.com
How buyback programs support MaxCyte Inc. (MYE0) stockDay Trade & AI Enhanced Execution Alerts - newser.com
Can MaxCyte Inc. stock resist market sell offsQuarterly Earnings Report & Verified Trade Idea Suggestions - newser.com
MaxCyte (MXCT) Projected to Post Quarterly Earnings on Wednesday - MarketBeat
What MACD signals say about MaxCyte Inc.2025 Top Gainers & Capital Efficient Trade Techniques - newser.com
MaxCyte, Inc. (NASDAQ:MXCT) Given Consensus Rating of "Hold" by Analysts - MarketBeat
Technical analysis overview for MaxCyte Inc. stockShare Buyback & Consistent Return Strategy Ideas - newser.com
Maxcyte Inc Azioni (MXCT) Dati Finanziari
Reddito
Reddito netto
Flusso di cassa
EPS
0.34%
14.63%
Apri su Yahoo
|
Apri su Google
|
Aperto in Finviz
|
Apri in MarketWatch
|
Aperto a EDGAR
|
Aperto su Reuters
Capitalizzazione:
|
Volume (24 ore):